المؤلفون: Thongtak A; Mahidol Wittayanusorn School, 364 Salaya, Phuttamonthon District, Nakhon Pathom 73170, Thailand., Yutisayanuwat K; Mahidol Wittayanusorn School, 364 Salaya, Phuttamonthon District, Nakhon Pathom 73170, Thailand., Harnkit N; Medicinal Plant Research Institute, Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand., Noikaew T; Department of Biology and Health Science, Mahidol Wittayanusorn School, 364 Salaya, Phuttamonthon District, Nakhon Pathom 73170, Thailand., Chumnanpuen P; Department of Zoology, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.; Omics Center for Agriculture, Bioresources, Food and Health, Kasetsart University (OmiKU), Bangkok 10900, Thailand.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 May 24; Vol. 25 (11). Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Cannabis*/chemistry , Dipeptidyl Peptidase 4*/metabolism , Dipeptidyl Peptidase 4*/chemistry , Dipeptidyl-Peptidase IV Inhibitors*/chemistry , Dipeptidyl-Peptidase IV Inhibitors*/pharmacology , Hypoglycemic Agents*/pharmacology , Hypoglycemic Agents*/chemistry , Peptides*/chemistry , Seeds*/chemistry, Humans ; Computational Biology/methods ; Hydrolysis ; Molecular Docking Simulation ; Plant Proteins/chemistry ; Seed Storage Proteins/chemistry

المؤلفون: Dhureja M; Department of Pharmaceutical Sciences & Technology, MRSPTU, Bathinda, India., Deshmukh R; Department of Pharmaceutical Sciences & Technology, MRSPTU, Bathinda, India; Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, India. Electronic address: drrahuld09@gmail.com.

المصدر: European journal of pharmacology [Eur J Pharmacol] 2024 Jul 15; Vol. 975, pp. 176635. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Lipopolysaccharides* , Uracil*/analogs & derivatives , Uracil*/pharmacology , Uracil*/therapeutic use , Piperidines*/pharmacology , Piperidines*/therapeutic use , Neuroprotective Agents*/pharmacology , Neuroprotective Agents*/therapeutic use , Dipeptidyl-Peptidase IV Inhibitors*/pharmacology , Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use , Oxidative Stress*/drug effects, Animals ; Male ; Rats ; Rats, Wistar ; Disease Models, Animal ; Parkinson Disease/drug therapy ; Parkinson Disease/metabolism ; Parkinson Disease/pathology ; Cytokines/metabolism ; Motor Activity/drug effects ; Corpus Striatum/drug effects ; Corpus Striatum/metabolism ; Corpus Striatum/pathology

المؤلفون: Sorokina L; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no.; Department of Chemistry, University of Oslo, Oslo, Norway., Solberg NT; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no., Koga S; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no., Rønning SB; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no., Afseth NK; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no., Wilson SR; Department of Chemistry, University of Oslo, Oslo, Norway., Rieder A; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no., Wubshet SG; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no.

المصدر: Food & function [Food Funct] 2024 Jul 15; Vol. 15 (14), pp. 7364-7374. Date of Electronic Publication: 2024 Jul 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101549033 Publication Model: Electronic Cited Medium: Internet ISSN: 2042-650X (Electronic) Linking ISSN: 20426496 NLM ISO Abbreviation: Food Funct Subsets: MEDLINE

مواضيع طبية MeSH: Dipeptidyl-Peptidase IV Inhibitors*/pharmacology , Dipeptidyl-Peptidase IV Inhibitors*/chemistry , Intestinal Absorption*/drug effects , Angiotensin-Converting Enzyme Inhibitors*/pharmacology , Angiotensin-Converting Enzyme Inhibitors*/chemistry , Angiotensin-Converting Enzyme Inhibitors*/metabolism , Dipeptidyl Peptidase 4*/metabolism , Protein Hydrolysates*/chemistry , Protein Hydrolysates*/pharmacology, Humans ; Caco-2 Cells ; Animals ; Peptides/chemistry ; Peptides/pharmacology ; Poultry ; Gastrointestinal Tract/metabolism ; Digestion ; Peptidyl-Dipeptidase A/metabolism ; Biological Availability ; Dipeptides/chemistry ; Dipeptides/pharmacology ; Dipeptides/metabolism

المؤلفون: Mima A; Department of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan akira.mima@ompu.ac.jp., Nakamoto T; Department of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Saito Y; Department of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Matsumoto K; Department of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Lee S; Department of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan.

المصدر: In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 1829-1833.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE

مواضيع طبية MeSH: Vildagliptin*/therapeutic use , Vildagliptin*/adverse effects , Vildagliptin*/administration & dosage , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Diabetic Nephropathies*/drug therapy , Glomerular Filtration Rate*/drug effects , Blood Glucose*/drug effects , Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use , Dipeptidyl-Peptidase IV Inhibitors*/adverse effects , Glycated Hemoglobin*/metabolism , Glycated Hemoglobin*/analysis , Adamantane*/analogs & derivatives , Adamantane*/therapeutic use , Adamantane*/adverse effects , Pyrrolidines*/therapeutic use , Pyrrolidines*/adverse effects , Pyrrolidines*/administration & dosage , Nitriles*/therapeutic use , Nitriles*/adverse effects , Nitriles*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; Creatinine/blood

المؤلفون: Suzuki Y; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Saitama, Japan., Kaneko H; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan. kanekohidehiro@gmail.com.; The Department of Advanced Cardiology, The University of Tokyo, Tokyo, Japan. kanekohidehiro@gmail.com., Okada A; Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Komuro J; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan., Fujiu K; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.; The Department of Advanced Cardiology, The University of Tokyo, Tokyo, Japan., Takeda N; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan., Morita H; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan., Ako J; Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan., Nishiyama A; Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan., Yano Y; Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.; Department of Family Medicine and Community Health Duke University Durham NC, Durham, NC, USA., Ieda M; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan., Node K; Department of Cardiovascular Medicine, Saga University, Saga, Japan., Yasunaga H; Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan., Komuro I; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.; International University of Health and Welfare, Tokyo, Japan.

المصدر: Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2024 Jul; Vol. 47 (7), pp. 1789-1796. Date of Electronic Publication: 2024 Apr 10.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9307690 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1348-4214 (Electronic) Linking ISSN: 09169636 NLM ISO Abbreviation: Hypertens Res Subsets: MEDLINE

مواضيع طبية MeSH: Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Sodium-Glucose Transporter 2 Inhibitors*/adverse effects , Hypertension*/drug therapy , Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use , Dipeptidyl-Peptidase IV Inhibitors*/adverse effects , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications, Humans ; Male ; Female ; Middle Aged ; Aged ; Incidence ; Blood Pressure/drug effects ; Adult

المؤلفون: Ashok A; DOS in Biotechnology, University of Mysore, Mysuru, India., H S A; DOS in Biotechnology, University of Mysore, Mysuru, India.

المصدر: Journal of molecular recognition : JMR [J Mol Recognit] 2024 Jul; Vol. 37 (4), pp. e3090. Date of Electronic Publication: 2024 May 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 9004580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1352 (Electronic) Linking ISSN: 09523499 NLM ISO Abbreviation: J Mol Recognit Subsets: MEDLINE

مواضيع طبية MeSH: Buffaloes* , Colostrum*/chemistry , Dipeptidyl-Peptidase IV Inhibitors*/chemistry , Dipeptidyl-Peptidase IV Inhibitors*/pharmacology , Dipeptidyl Peptidase 4*/chemistry , Dipeptidyl Peptidase 4*/metabolism , Molecular Docking Simulation* , Computational Biology* , Peptides*/chemistry , Peptides*/pharmacology, Animals ; Prolyl Oligopeptidases/metabolism ; Prolyl Oligopeptidases/chemistry ; Humans ; Serine Endopeptidases/chemistry ; Serine Endopeptidases/metabolism ; Amino Acid Sequence ; Computer Simulation ; Female

المؤلفون: Wang X; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science, Tianjin, China., Liu H; Clinical Pharmacology Research Center, Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, Beijing, China., Cui C; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China., Niu X; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China., Li H; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China., Niu S; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, FL, USA., Yan P; Haisco Pharmaceutical Group Co. Ltd., Chengdu, China., Wu N; Haisco Pharmaceutical Group Co. Ltd., Chengdu, China., Li F; Haisco Pharmaceutical Group Co. Ltd., Chengdu, China., Wu Q; Haisco Pharmaceutical Group Co. Ltd., Chengdu, China., Chen K; Haisco Pharmaceutical Group Co. Ltd., Chengdu, China., Hu B; Clinical Pharmacology Research Center, Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, Beijing, China., Liu D; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.

المصدر: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Jul; Vol. 13 (7), pp. 716-728. Date of Electronic Publication: 2024 May 17.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

مواضيع طبية MeSH: Dipeptidyl-Peptidase IV Inhibitors*/pharmacokinetics , Dipeptidyl-Peptidase IV Inhibitors*/administration & dosage , Dipeptidyl-Peptidase IV Inhibitors*/adverse effects , Dose-Response Relationship, Drug* , Electrocardiography*/drug effects , Healthy Volunteers* , Heart Rate*/drug effects, Adult ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; Double-Blind Method ; Long QT Syndrome/chemically induced ; East Asian People

المؤلفون: Aljohani H; Drug Safety and Risk Management Department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia. hialjehani@gmail.com., Alrubaish FS; Drug Safety and Risk Management Department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Alghamdi WM; Drug Safety and Risk Management Department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Al-Harbi F; Drug Safety and Risk Management Department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.

المصدر: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Jul; Vol. 58 (4), pp. 622-633. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2168-4804 (Electronic) Linking ISSN: 21684790 NLM ISO Abbreviation: Ther Innov Regul Sci Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use , Dipeptidyl-Peptidase IV Inhibitors*/adverse effects , Linagliptin*/therapeutic use , Linagliptin*/adverse effects , Randomized Controlled Trials as Topic*, Humans ; Cardiovascular Diseases/chemically induced ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/adverse effects

المؤلفون: Wang M; Department of Ophthalmology, Changxing County People's Hospital, 66 Taihu Middle Road, Zhicheng Town, Changxing County, Huzhou city, Zhejiang Province, China., Lu J; Department of Ophthalmology, Changxing County People's Hospital, 66 Taihu Middle Road, Zhicheng Town, Changxing County, Huzhou city, Zhejiang Province, China., Dong J; Department of Ophthalmology, Changxing County People's Hospital, 66 Taihu Middle Road, Zhicheng Town, Changxing County, Huzhou city, Zhejiang Province, China. 15857288244@163.com.

المصدر: BMC ophthalmology [BMC Ophthalmol] 2024 Jun 28; Vol. 24 (1), pp. 272. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415 (Electronic) Linking ISSN: 14712415 NLM ISO Abbreviation: BMC Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Diabetic Retinopathy*/drug therapy , Dipeptidyl-Peptidase IV Inhibitors*/adverse effects , Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use, Humans ; Incidence ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/complications ; Risk Factors ; Disease Progression

المؤلفون: Fu EL; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands., Wexler DJ; Diabetes Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Cromer SJ; Diabetes Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Bykov K; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA, USA., Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

المصدر: BMJ (Clinical research ed.) [BMJ] 2024 Jun 26; Vol. 385, pp. e078483. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Hyperkalemia*/chemically induced , Hyperkalemia*/epidemiology , Sodium-Glucose Transporter 2 Inhibitors*/adverse effects , Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use , Dipeptidyl-Peptidase IV Inhibitors*/adverse effects , Glucagon-Like Peptide-1 Receptor*/agonists, Humans ; Male ; Female ; Aged ; Middle Aged ; United States/epidemiology ; Cohort Studies ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Propensity Score ; Glucagon-Like Peptide-1 Receptor Agonists